Ania M. Jastreboff, MD, PhD, shares details about the results of the SURMOUNT-1 phase 3 obesity trial of tirzepatide. Dr. Jastreboff helped present findings Saturday during the Scientific Sesssions, and a recording of that presentation can be found at ADA2022.org.